Literature DB >> 7904270

Beta-adrenergic agonists regulate KCa channels in airway smooth muscle by cAMP-dependent and -independent mechanisms.

H Kume1, I P Hall, R J Washabau, K Takagi, M I Kotlikoff.   

Abstract

Stimulation of calcium-activated potassium (KCa) channels in airway smooth muscle cells by phosphorylation-dependent and membrane-delimited, G protein actions has been reported (Kume, H. A. Takai, H. Tokuno, and T. Tomita. 1989. Nature [Lond.]. 341:152-154; Kume, H., M. P. Graziano, and M. I. Kotlikoff. 1992. Proc. Natl. Acad. Sci. USA. 89:11051-11055). We show that beta-adrenergic receptor/channel coupling is not affected by inhibition of endogenous ATP, and that activation of KCa channels is stimulated by both alpha S and cAMP-dependent protein kinase (PKA). PKA stimulated channel activity in a dose-dependent fashion with an EC50 of 0.12 U/ml and maximum stimulation of 7.38 +/- 2.04-fold. Application of alpha S to patches near maximally stimulated by PKA significantly increased channel activity to 15.1 +/- 3.65-fold above baseline, providing further evidence for dual regulatory mechanisms and suggesting that the stimulatory actions are independent. Analysis of channel open-time kinetics indicated that isoproterenol and alpha S stimulation of channel activity primarily increased the proportion of longer duration events, whereas PKA stimulation had little effect on the proportion of short and long duration events, but resulted in a significant increase in the duration of the long open-state. cAMP formation during equivalent relaxation of precontracted muscle strips by isoproterenol and forskolin resulted in significantly less cAMP formation by isoproterenol than by forskolin, suggesting that the degree of activation of PKA is not the only determinant of tissue relaxation. We conclude that beta-adrenergic stimulation of KCa channel activity and relaxation of tone in airway smooth muscle occurs, in part, by means independent of cyclic AMP formation.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7904270      PMCID: PMC293787          DOI: 10.1172/JCI116969

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  34 in total

1.  Regulation of Ca(2+)-activated K+ channels by protein kinase A and phosphatase inhibitors.

Authors:  A Carl; J L Kenyon; D Uemura; N Fusetani; K M Sanders
Journal:  Am J Physiol       Date:  1991-08

2.  Effects of intracellular pH on calcium-activated potassium channels in rabbit tracheal smooth muscle.

Authors:  H Kume; K Takagi; T Satake; H Tokuno; T Tomita
Journal:  J Physiol       Date:  1990-05       Impact factor: 5.182

3.  Arterial dilations in response to calcitonin gene-related peptide involve activation of K+ channels.

Authors:  M T Nelson; Y Huang; J E Brayden; J Hescheler; N B Standen
Journal:  Nature       Date:  1990-04-19       Impact factor: 49.962

4.  Hyperpolarizing vasodilators activate ATP-sensitive K+ channels in arterial smooth muscle.

Authors:  N B Standen; J M Quayle; N W Davies; J E Brayden; Y Huang; M T Nelson
Journal:  Science       Date:  1989-07-14       Impact factor: 47.728

5.  The cyclic AMP-dependent protein kinase catalytic subunit selectively enhances calcium currents in rat nodose neurones.

Authors:  R A Gross; M D Uhler; R L Macdonald
Journal:  J Physiol       Date:  1990-10       Impact factor: 5.182

6.  Selective inhibition of relaxation of guinea-pig trachea by charybdotoxin, a potent Ca(++)-activated K+ channel inhibitor.

Authors:  T R Jones; L Charette; M L Garcia; G J Kaczorowski
Journal:  J Pharmacol Exp Ther       Date:  1990-11       Impact factor: 4.030

7.  Regulation of Ca2+-dependent K+-channel activity in tracheal myocytes by phosphorylation.

Authors:  H Kume; A Takai; H Tokuno; T Tomita
Journal:  Nature       Date:  1989-09-14       Impact factor: 49.962

8.  Lack of correlation between activation of cyclic AMP-dependent protein kinase and inhibition of contraction of rat vas deferens by cyclic AMP analogs.

Authors:  Y J Hei; K L MacDonell; J H McNeill; J Diamond
Journal:  Mol Pharmacol       Date:  1991-02       Impact factor: 4.436

9.  Regular inhaled beta-agonist treatment in bronchial asthma.

Authors:  M R Sears; D R Taylor; C G Print; D C Lake; Q Q Li; E M Flannery; D M Yates; M K Lucas; G P Herbison
Journal:  Lancet       Date:  1990-12-08       Impact factor: 79.321

Review 10.  Cyclic AMP and mechanisms of vasodilation.

Authors:  K J Murray
Journal:  Pharmacol Ther       Date:  1990       Impact factor: 12.310

View more
  55 in total

Review 1.  Pharmacogenetics of asthma.

Authors:  A Fenech; Ian P Hall
Journal:  Br J Clin Pharmacol       Date:  2002-01       Impact factor: 4.335

2.  Protein kinase A-independent responses to beta-adrenoceptor agonists.

Authors:  G Dent
Journal:  Br J Pharmacol       Date:  2001-08       Impact factor: 8.739

3.  cAMP-independent relaxation of smooth muscle cells via Gs-coupled receptors.

Authors:  Stephan L Peters; Martin C Michel
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-11       Impact factor: 3.000

Review 4.  Regulation of heterotrimeric G protein signaling in airway smooth muscle.

Authors:  Raymond B Penn; Jeffrey L Benovic
Journal:  Proc Am Thorac Soc       Date:  2008-01-01

Review 5.  Embracing emerging paradigms of G protein-coupled receptor agonism and signaling to address airway smooth muscle pathobiology in asthma.

Authors:  Raymond B Penn
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-02-16       Impact factor: 3.000

6.  Role of Airway Smooth Muscle in Inflammation Related to Asthma and COPD.

Authors:  Hiroaki Kume
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

7.  Beta 2 adrenoceptor polymorphisms: are they clinically important?

Authors:  I P Hall
Journal:  Thorax       Date:  1996-04       Impact factor: 9.139

8.  Theophylline attenuates Ca2+ sensitivity and modulates BK channels in porcine tracheal smooth muscle.

Authors:  Shinji Ise; Junji Nishimura; Katsuya Hirano; Nobuyuki Hara; Hideo Kanaide
Journal:  Br J Pharmacol       Date:  2003-09-29       Impact factor: 8.739

9.  Combined inhaled salbutamol and mannitol therapy for mucus hyper-secretion in pulmonary diseases.

Authors:  Hui Xin Ong; Daniela Traini; Giulia Ballerin; Lucy Morgan; Lachlan Buddle; Santo Scalia; Paul M Young
Journal:  AAPS J       Date:  2014-01-16       Impact factor: 4.009

10.  In vitro and in silico studies of 8(17),12E,14-labdatrien-18-oic acid in airways smooth muscle relaxation: new molecular insights about its mechanism of action.

Authors:  Edilson B Alencar Filho; Luciano A A Ribeiro; Thiego G C Carvalho; Fabrício S Silva; Luiz Antonio M S Duarte-Filho; Euzébio G Barbosa; Pedro M N Menezes; Josean F Tavares; Marcelo S da Silva; Bagnólia A Silva
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2020-11-18       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.